Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-04-22

FDA Approved: PHYTONADIONE — Original Application (Cipla USA Inc.)

View source ↗

Summary

FDA approved Cipla USA Inc.'s original application for phytonadione (vitamin K1), a generic product. The approval authorizes marketing of this generic vitamin K…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PHYTONADIONE (phytonadione)

Snippet

ORIG AP for PHYTONADIONE (PHYTONADIONE)